# Prevention of Liver Damage During Liver Surgery

> **NCT00845689** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Ludwig-Maximilians - University of Munich**

## Conditions studied

- Liver Tumors

## Interventions

- **DRUG:** placebo
- **DRUG:** adenosine
- **DRUG:** adenosine
- **PROCEDURE:** Liver resection

## Key facts

- **NCT ID:** NCT00845689
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2009-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00845689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00845689, "Prevention of Liver Damage During Liver Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00845689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*